Live Chat Software

Exclusive Content

McKesson on: The Largest Challenges in Preparing for DSCSA Saleable Returns Verification

McKesson on: The Largest Challenges in Preparing for DSCSA Saleable Returns Verification

We caught up with Kevan MacKenzie, Director of Serialization Technology at McKesson, to learn about wholesaler-distributors largest challenges in preparing for DSCSA saleable returns verification in 2019.

In addition to discussing wholesaler-distributors current challenges, MacKenzie also reveals: 

  • His advice for those who are experiencing difficulty in getting ready for saleable returns and exception management
  • The implications that varying global regulations creates for wholesaler-distributors 
  • A look at where the industry currently stands regarding interoperability and what it will take to meet the 2023 deadline
  • What you can expect to learn from his presentation at the upcoming Pharmaceutical Traceability Forum this November in Philadelphia 
  • And more!
[Interactive Report] Creating Value Beyond 2023 Compliance: Challenges, Strategies and Solutions

[Interactive Report] Creating Value Beyond 2023 Compliance: Challenges, Strategies and Solutions

How can the pharmaceutical industry create value beyond 2023 compliance? This interactive report takes a look at the specific challenges faced by every point in the supply chain   as well as their strategies and solutions for the future. This report will help you to discover how to get maximum value from your serialization and traceability initiatives, as well as how to reap the benefits of full supply chain visibility.

Specifically, this interactive report takes a look at:

  • Operationalizing serialization in 2018
  • Verification challenges and opportunities for 2019
  • Dispenser challenges and successes ahead of the 2020 deadline
  • In reality, what will the supply chain look like in 2023?
  • And much more!
Expert Insight into Top Pharmaceutical Challenges Surrounding Serialization: Aggregation and CMO Integration

Expert Insight into Top Pharmaceutical Challenges Surrounding Serialization: Aggregation and CMO Integration

In anticipation of the Pharmaceutical Traceability Forum, we spoke with Matt Sample and Christopher Howell about the top pharmaceutical challenges surrounding Serialization: Aggregation and CMO Integration. Both speakers shared their unique perspectives on the topic and also expressed what they were most excited to learn about at the upcoming event. 

Preparing for 2023: Advice from a Top Wholesaler

Preparing for 2023: Advice from a Top Wholesaler

In advance of the Forum, we spoke with an elite representative from the wholesaler side of pharmaceutical shipping about the plans his company has and the challenges he’s facing. Take these into consideration today for best results 7 years from now.

Serialisation Case Studies: SMEs and CMOs

Serialisation Case Studies: SMEs and CMOs

Pharma IQ spoke with Mark Davison, Chief Executive Officer at Blue Sphere Health Ltd, and Vetter Pharma to gain insight into SME pharma & biotechs for serialization, as well as strategies that CMOs can implement to succeed in serialization.
Pharmaceutical Traceability Industry Experts eBook

Pharmaceutical Traceability Industry Experts eBook

Before you hear from these great speakers at the Forum, read their thoughts on serialization within the life sciences industry. We sat down with speakers from top companies such as AmerisourceBergen, Merck & Co., NC Mutual Wholesale Drug Company and Neurocrine Biosciences, find out what they had to say!
Pharmaceutical Serialization and Traceability 2017 Trend Report

Pharmaceutical Serialization and Traceability 2017 Trend Report

With time running low, Pharma Logistics IQ tracks the state of the industry’s serialization projects. This year’s research report maps out and measures the changes in consensus as the industry advances closer to an entirely track-and-trace pharmaceutical environment. Sections covered:

  • Project Planning
  • Implementation Progress
  • Traceability In Operation 
  • Benefits Beyond Compliance
Working with CMOs: Serialization Tends to Fail in the Details

Working with CMOs: Serialization Tends to Fail in the Details

This is the second article in a series looking at how to avoid the supply risk when working with CMOs on serialization. In this article I will discuss another six learnings covering everything from resource-planning to clarifying your RACI.
The Final Stages of Serialization

The Final Stages of Serialization

Pharma IQ conducted extensive market research to pinpoint the concerns and priorities of those in the more mature phases of serialization.
Software Best Practices: Implementation & Data Integration

Software Best Practices: Implementation & Data Integration

Effective data management is imperative to achieve regulatory compliance with a serialisation programme. Non-standard data exchange and integration methods are seen as one of the biggest hurdles in serialisation compliance. In light of the data responsibilities expected within serialisation projects, Pharma IQ consults with a selection of experts on software best practices - data integration and implementation.
Traceability in Operation Market Research: Concerns and Priorities

Traceability in Operation Market Research: Concerns and Priorities

Pharma IQ collected the following market research to pinpoint the concerns and priorities of those in the more mature phases of serialization. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability.
Drug Supply Chain Security Act (DSCSA) Interactive Implementation Timeline

Drug Supply Chain Security Act (DSCSA) Interactive Implementation Timeline

The Drug Quality and Security Act (DQSA), was enacted by Congress on November 27, 2013. Title II of DQSA, the Drug Supply Chain Security Act (DSCSA), outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. This will enhance FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. The system will also improve detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers.

To help ensure you meet the November, 23, 2023 deadline, we created this  interactive presentation that sheds light on the upcoming deadlines, requirements and other need-to-know information.

Tracking & Tracing Serialization in 2018

Tracking & Tracing Serialization in 2018

We created a map to provide an overview of various countries and their serialization journey, as global deadlines are approaching fast. By 2020, serialization is anticipated to cover 80% of the global drug supply. This map takes a look at the United States, European Union, Brazil, Turkey, Egypt, Australia, China, India, South Korea, Russia, and many more. 

Serialization Track & Trace Global Updates 2018

Serialization Track & Trace Global Updates 2018

By 2020, serialization is expected to cover 80% of the global drug supply, but disparity between regulations in different parts of the world means high costs and complexity for companies in the supply chain. As global deadlines loom, we have created this video to provide an overview of various nations journey to serialization.

To a request a copy via email >>> enquiryiqpc@iqpc.com

Serialization World Map

Serialization World Map

Pharma IQ have created an updated serialisation printable world map to assist with your worldwide serialisation compliance strategies and help the industry prepare for these various approaching deadlines all over the globe.

FDA Vision For 2023

FDA Vision For 2023

Ahead of the 6th Pharmaceutical Traceability Forum, December 7 -8, we interviewed members of our speaker faculty on their immediate impressions of the FDA meeting that was held in August. Get your copy of this exclusive interview to find out what the FDA vision of the future is for 2023!